Jin Medical International Ltd. (ZJYL)

NASDAQ: ZJYL · Real-Time Price · USD

0.1451

-0.0062 (-4.10%)

At close: Feb 27, 2026, 4:00 PM EST

0.1481

+0.0030 (2.07%)

After-hours: Feb 27, 2026, 6:56 PM EST

Jin Medical International Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	20.69	23.5	19.82	19.19	20.76
Revenue Growth (YoY)	-11.98%	18.57%	3.29%	-7.58%	28.22%
Cost of Revenue	14.44	13.89	12.86	12.83	14.18
Gross Profit	6.24	9.61	6.96	6.36	6.59
Selling, General & Admin	3.88	4.37	2.37	2.18	2.16
Research & Development	1.56	1.5	1.54	1.89	1.57
Other Operating Expenses	0.2	0.11	0.18	0.16	0.23
Operating Expenses	5.63	5.97	4.1	4.23	3.95
Operating Income	0.61	3.64	2.87	2.13	2.63
Interest Expense	-	-	-	-	-0.01
Interest & Investment Income	0.79	0.47	0.18	0.18	-
Currency Exchange Gain (Loss)	0.02	-0.03	-0.05	0.19	0.06
Other Non Operating Income (Expenses)	0.18	0.11	0.22	0.24	0.19
Pretax Income	1.6	4.18	3.22	2.74	2.88
Income Tax Expense	0.21	0.76	0.34	0.04	0.25
Earnings From Continuing Operations	1.38	3.42	2.88	2.71	2.63
Minority Interest in Earnings	-0.19	0.26	-	-	-
Net Income	1.19	3.68	2.88	2.71	2.63
Net Income to Common	1.19	3.68	2.88	2.71	2.63
Net Income Growth	-67.59%	27.71%	6.34%	2.84%	19.30%
Shares Outstanding (Basic)	157	156	145	135	135
Shares Outstanding (Diluted)	157	156	145	135	135
Shares Change (YoY)	0.05%	7.81%	7.51%	-	-66.25%
EPS (Basic)	0.01	0.02	0.02	0.02	0.02
EPS (Diluted)	0.01	0.02	0.02	0.02	0.02
EPS Growth	-67.61%	18.46%	-1.08%	2.84%	253.54%
Free Cash Flow	-3.73	-1.35	2.99	1.54	5.8
Free Cash Flow Per Share	-0.02	-0.01	0.02	0.01	0.04
Gross Margin	30.18%	40.89%	35.14%	33.13%	31.72%
Operating Margin	2.94%	15.48%	14.46%	11.10%	12.67%
Profit Margin	5.76%	15.64%	14.52%	14.10%	12.67%
Free Cash Flow Margin	-18.01%	-5.75%	15.10%	8.03%	27.93%
EBITDA	0.85	3.88	3.09	2.49	2.98
EBITDA Margin	4.12%	16.50%	15.60%	12.99%	14.34%
D&A For EBITDA	0.24	0.24	0.23	0.36	0.35
EBIT	0.61	3.64	2.87	2.13	2.63
EBIT Margin	2.94%	15.48%	14.46%	11.10%	12.67%
Effective Tax Rate	13.45%	18.26%	10.67%	1.32%	8.63%
Revenue as Reported	20.69	23.5	19.82	19.19	20.76

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q